Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):330–341. doi: 10.1097/QAI.0000000000001925

Table 1.

Baseline Characteristics of Study Population



Variable
30-day readmission
N=140
No 30-day readmission
N=661
Total

N=801
Demographics
Age, mean years (range) 44.8
(22–67)
44
(18–68)
44.1
(18–68)
Male gender 91
(65%)
449
(67.9%)
540
(67.4%)
Race/ethnicity
 Non-Hispanic white
 Non-Hispanic black
 Hispanic
 Other

19 (13.8%)
108 (77.1%)
10 (7.1%)
3 (2.1%)

77 (11.7%)
495 (74.9%)
78 (11.8%)
11 (1.7%)

96 (12.0%)
603 (75.3%)
88 (11.0%)
14 (1.7%)
HIV risk factor
 IDU
 MSM+IDU
 MSM
 Heterosexual

41 (29.3%)
2 (1.4%)
17 (12.1%)
80 (57.1%)

175 (26.5%)
41 (6.4%)
129 (19.5%)
315 (47.7%)

216 (26.8%)
44 (5.4%)
146 (18.2%)
395 (49.3%)
Marital status
 Married
 Widowed
 Divorced
 Separated
 Never married
 Living with partner

10 (7.1%)
7 (5%)
16 (11.4%)
9 (6.4%)
90 (64%)
8 (5.7%)

36 (5.5%)
21 (3.2%)
76 (11.5%)
52 (7.9%)
440(66.6%)
36 (5.5%)

46 (5.7%)
28 (3.5%)
92 (11.5%)
61 (7.6%)
530 (66.2%)
44 (5.5%)
Socio-economic
Education
 < High school
 High school/GED
 >High school

54 (38.6%)
48 (34.3%)
38 (27.1%)

265 (40.1%)
223 (37.7%)
173 (26.2%)

319 (39.8%)
271 (33.8%)
211 (26.3%)
Income, annual
 $0
 $1–5000
 $5001–10,000
 $10,001–20,000
 >$20,000
 Missing

19 (13.6%)
18 (12.9%)
44 (31.4%)
12 (8.6%)
5 (3.6%)
42 (30%)

60 (9.1%)
65 (9.8%)
208(31.5%)
76 (11.5%)
58 (8.8%)
194(29.4%)

79 (9.9%)
83 (10.4%)
252 (31.5%)
88 (11.0%)
63 (7.9%)
236 (29.5%)
Insurance
 Any
 Medicaid
 Medicare
 Dual
 Private
 Other

102 (73.4%)
60 (42.9%)
5 (3.6%)
14 (10.0%)
1 (1%)
22 (15.7%)

432 (65.9%)
211 (31.9%)
46 (7.0%)
38 (5.6%)
21 (4.9%)
116 (17.6%)

534 (67.2%)
271 (33.8%)
51 (6.4%)
52 (6.5%)
22 (4%)
138 (17.2%)
Employment
 Working
 Unemployed
 Disabled
 Other

9 (6.4%)
47 (33.5%)
75 (53.6%)
9 (6.4%)

84 (12.7%)
234 (35.4%)
324 (49.0%)
19 (2.9%)

93 (11.6%)
281 (35.1%)
399 (49.8%)
28 (3.5%)
Food insecurity
 Any
 Mild
 Moderate
 Severe

93 (66.4%)
10 (7.1%)
25 (17.9%)
58 (41.4%)

381 (57.6%)
80 (12.1%)
88 (13.3%)
209 (31.7%)

474 (59.2%)
90 (11.3%)
113 (14.1%)
267 (33.4%)
Housing (N=791)*
 Homeless/shelter
 Transitional housing/group home
 With friends/family
 Rent/own apartment/home

22 (15.8%)
12 (8.6%)
43 (30.9%)
62 (44.6%)

101(15.5%)
60 (9.2%)
175(26.8%)
316(48.5%)

123 (15.6%)
72 (9.1%)
218 (27.6%)
378 (47.8%)
Socio-behavioral
Prior Incarceration
 Lifetime
 Past 6 months

111 (79.9%)
20 (14.4%)

509 (77.1%)
101 (15.3%)

620 (77.6%)
121 (15.1%)
Substance use (past 12 months)
Stimulants (crack, cocaine, meth)
 Crack
 Powder cocaine
 Methamphetamines
Opiates (heroin, pain pills)
 Heroin
 Pain pills
Marijuana
Ecstasy

101 (72.1%)
69 (49.3%)
48 (34.3%)
4 (2.9%)
30 (21.4%)
25 (17.9%)
10 (7.1%)
57 (40.7%)
6 (4.3%)

455 (68.8%)
302 (45.7%)
205 (31.0%)
65 (9.8%)
142 (21.5%)
18 (17.9%)
38 (5.8%)
301 (45.5%)
31 (4.7%)

556 (69.4%)
371 (46.3%)
253 (31.6%)
69 (8.6%)
172 (21.5%)
143 (17.9%)
48 (6.0%)
358 (44.7%)
37 (4.6%)
Substance use
 AUDIT (>7 for men, >6 for women)
 DAST-10 (≥6)
 Severe substance use (AUDIT or DAST-10)

62 (44.3%)
59 (41.6%)
92 (66.7%)

287 (43.4%)
275 (42.1%)
441 (65.7%)

349 (43.6%)
334 (41.7%)
553 (66.5%)
Substance use treatment attitudes, mean (SD)
 Readiness
 Negative attitude

13.6 (4.5)
13.1 (3.6)

14.3 (4.1)
13.3 (3.5)

14.2 (4.2)
13.3 (3.5)
Smoking history 38 (27.1%) 203 (30.7%) 241 (30.1%)
Adherence to HIV medications in last month
 Taking >85% of pills
 ART pills taken in last mo,% (mean,SD)

26 (18.6%)
56.7 (36.6)

110 (16.6%)
57.3 (37.6)

136 (17.0%)
57.2 (37.3)
Adherence self efficacy (mean, SD)
 Integration
 Perseverance
 Total score

66.8 (22.8)
22.1 (8.4)
88.8 (29.8)

68.1 (21.4)
22.6 (7.7)
90.7 (28.0)

67.9 (21.7)
22.5 (7.8)
90.4 (28.3)
Patient provider relationship (N=548)* (mean, SD)
 Satisfaction
 Trust
 Total

13.9 (4.0)
24.2 (5.0)
108.2 (27.8)

13.8 (4.0)
24.4 (4.7)
107.6 (26.1)

13.8 (4.0)
24.3 (4.8)
107.7 (26.4)
Medical mistrust (mean, SD) 29.3 (7.8) 28.5 (7.8) 28.7 (7.8)
Health literacy (mean, SD) 8.6 (3.2) 9.1 (3.1) 9.0 (3.1)
Perceived health status (mean, SD) 32.3 (9.5) 34.0 (9.0) 33.7 (9.2)
Interpersonal violence, any 103 (73.6%) 439 (66.4%) 542 (67.7%)
Psychological distress (BSI)
 Anxiety/panic
 Somatization
 Depression
 Total score

68 (48.6%)
81 (57.9%)
68 (48.6%)
84 (60%)

298 (45.0%)
385 (58.2%)
271 (41.0%)
347 (52.5%)

366 (45.7%)
466 (58.2%)
339 (42.3%)
431 (53.8%)
Social support/ conflictual interaction 22.0 (7.7) 22.0 (7.5) 22.0 (7.5)
Access to care (mean, SD) 6.3 (4.7) 6.2 (4.8) 6.2 (4.8)
Distance from hospital, miles (mean, SD)
Median miles, IQR
5.8 (7.4)
4.5 (2.2, 7.6)
12.2 (53.8)
4.1 (2.2,7.2)
11.1 (49.0)
4.2 (2.2,7.5)
Hospitalization details
Length of hospital stay, days (mean SD) 6.5 (5.7) 6.5 (7.1) 6.5 (6.9)
Primary diagnosis on admission
 AIDS defining illness
 Infection, non AIDS defining
  CD4<200
 Cardiovascular
 Endocrine/Nutrition/Electrolytes/Other
 Gastrointestinal/Liver
 Hematology/Oncology
 Injury
 Neurology
 Psychiatry
 Pulmonary
 Renal
 Substance use

15 (10.7%)
47 (33.6%)
40 (28.6%)
18 (12.9%)
7 (5.0%)
22 (15.7%)
2 (1.4%)
0 (0%)
7 (5.0%)
5 (3.7%)
11 (7.9%)
3 (2.1%)
3 (2.1%)

61 (9.3%)
247 (37.4%)
167 (25.3%)
46 (7.0%)
30 (4.5%)
59 (8.9%)
13 (2.0%)
38 (5.8%)
41 (6.2%)
14 (2.1%)
87 (13.2%)
15 (2.3%)
9 (1.4%)

76 (9.5%)
294 (36.8%)
207 (25.8%)
64 (8.0%)
37 (4.6%)
81 (10.1%)
15 (1.9%)
38 (4.8%)
48 (6.0%)
19 (2.4%)
98 (12.3%)
18 (2.3%)
12 (1.5%)
On ART prior to admission 62 (44.3%) 247 (37.4%) 390 (38.6%)
Started on ART during admission 25 (17.9%) 99 (15.0%) 124 (15.5%)
Discharged with supply of ART 23 (16.4%) 120 (18.3%) 143 (18.0%)
Referrals received as inpatient
 Case management
 Drug treatment
 Housing
 Mental health
 Outpatient HIV clinic
 Any referral

23 (16.4)
18 (12.9%)
14 (10.0%)
13 (9.3%)
78 (55.7%)
91 (65%)

146 (22.3%)
109 (16.6%)
92 (14.0%)
56 (8.5%)
375 (57.2%)
448 (67.8%)

169 (21.2%)
127 (16.0%)
106 (13.3%)
69 (8.7%)
453 (56.9%)
539 (67.3%)
Laboratory values/illness severity
CD4 count
 ≤50
 51–200
 >200

62 (44.3%)
37 (26.4%)
41 (29.3%)

207 (31.3%)
224 (33.9%)
230 (34.8%)

269 (33.6%)
261 (32.6%)
271(33.8%)
HIV viral load
 Median (IQR), x1000 copies/mL

 Undetectable ≤200 copies/mL
 ≤1000
 1001–10,000
 10,001–100,000
 >100,000

56.5
(3.8–229.6)
18 (12.9%)
28 (20.0%)
18 (12.9%)
37 (26.4%)
57 (40.7%)

52.4
(6.6–194.8)
69 (10.4%)
110 (16.6%)
76 (11.5%)
227 (34.3%)
248 (37.5%)

52.8
(5.2–199.2)
87 (10.9%)
138 (17.2%)
94 (11.7%)
264 (33.0%)
305 (38.1%)
HCV Ab positive (N=559)* 35 (37.6%) 168 (36.1%) 203 (36.3%)
Laboratory values
 WBC < 4.2 × 10(9)/L
 Absolute lymphocytes < 1.3 × 10(9)/L
 HCT <39.6% (men), <34.1% (women)
 Creatinine <0.67(mg/dL)
 Creatinine >1.17 (mg/dL)
 AST > 50 U/L (men) or >35 U/L (women)
 ALT > 50 U/L (men) or >35 U/L (women)

128 (91.4%)
106 (75.7%)
108 (77.1%)
21 (15.0%)
43 (30.7%)
56 (40%)
35 (25%)

562 (85.0%)
466 (70.5%)
455 (68.8%)
82 (12.4%)
144 (21.8%)
224 (33.9%)
132 (20.0%)

690 (86.1%)
572 (71.4%)
563 (70.3%)
103 (12.9%)
187 (23.4%)
280 (35.0%)
167 (20.9%)
HIV-dementia scale (≤ 10) 44 (31.4%) 162 (24.5%) 206 (25.7%)
Karnofsky ≥ 60 and < 80 69 (49.3%) 265 (40.1%) 334 (41.7%)
Healthcare utilization
HIV primary care visit in past 6 months 66 (47.1%) 299 (45.2%) 365 (45.6%)
ED visits in past 12 months
 ≤1
 2–4
 ≥ 5

31 (22.1%)
66 (47.1%)
43 (30.7%)

289 (43.7%)
272 (41.1%)
100 (15.1%)

320 (40.0%)
338 (42.2%)
143 (17.6%)
Hospitalizations in past 6 months
 0
 1
 ≥2

34 (24.3%)
42 (30.0%)
64 (45.7%)

321 (48.6%)
172 (26.0%)
168 (25.4%)

355 (44.3%)
214 (26.7%)
232 (29.0%)
*

for missing data, revised N is noted

Categorical measures are depicted as n (%).

IDU= injection drug use; MSM= men who have sex with men; GED= General Education Diploma; AUDIT= alcohol use disorders identification test; DAST-10= drug abuse screening test; SD= standard deviation; BSI=brief symptom inventory; IQR= interquartile range; AIDS= acquired immune deficiency syndrome; ART= antiretroviral therapy; HCV Ab =hepatitis C virus antibody; WBC= white blood cell count; HCT= hematocrit; AST= aspartate aminotransferase; ALT= alanine aminotransferase; ED= emergency department